Trial intelligence / Profile preview

Roflumilast foam in pediatric non-segmental vitiligo

NCT07105254Phase 2Recruiting

Sponsor
DermTexas
Start
Aug 2025
Primary completion
May 2026
Countries
1
01

Overview

A Phase 2 trial of roflumilast vehicle cream in Vitiligo, sponsored by DermTexas. Started Aug 2025; status: recruiting.

02

Drugs

roflumilast vehicle cream
03

Conditions

Vitiligo

Beyond the preview

Go deeper on NCT07105254.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07105254.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call